EVALUATION OF THE EFFECTIVENESS OF LASER REMOVAL OF VIRAL WARTS
Keywords:
viral warts, papillomavirus (HPV), laser destruction, VBeam Perfecta laser (Candela)Abstract
One of the serious problems of modern medicine is the treatment of warts. Due to their prevalence, patient discomfort and extensive prospects for complications. In recent years, laser therapy has become an effective method with benefits such as safety, convenience, painlessness, reduced side effects and rapid recovery. In this study, we evaluated the effectiveness of the VBeam Perfecta laser (manufactured by Candela) in the treatment of warts. The results show that this laser method is promising for patients with warts and can be recommended as a treatment method.
References
Dmitriev G.A., Bitkina O.A. Papillomavirus infection. — M.: Medical book, 2006. — 77 p.
Ershov V.A., Narvskaya O.V. Background processes and neoplasia of the cervical epithelium. — St. Petersburg: LLC "Man", 2007. — 80 p.
Kiselev V.I. Human papillomavirus in the development of cervical cancer. — M., 2004. — 179 p.
Krasnopolsky V.I., Logutova L.S., Serova O.F., Besova N.V., Tumanova V.A., 3arochentseva N.V., Barinova I.V. Possibilities of using the cytological method of cervical examination in pregnant women // Russian bulletin of obstetrician gynecologist. - 2009. — No. 3. — pp. 83-86.
Kuevda D.A., Shipulina O.Yu. Genodiagnostics of genital papillomavirus infection: algorithms of use and requirements for tests // Papillomavirus infection and malignant neoplasms. integrated surveillance and prevention system: proceedings of the International the symposium. — St. Petersburg: NIIEM im. Pasteur, 2009. — 120 p.
Kulakov V.I., Prilepskaya V.N. Prevention of cervical cancer: a guide for doctors. — M.: MEDpress-inform, 2008. — 56 p.
Lyalina L.V. Infections and cancer: prospects for the development of a unified
system of epidemiological surveillance and prevention // Papillomavirus infection and malignant neoplasms. integrated surveillance and prevention system: materials of the International the symposium. — St. Petersburg: NIIEM im. Pasteur, 2009. — pp. 7-11.
Lyalina L.V., Noskov F.S., Zhebrun A.B., Narvskaya O.V., Merabishvili V.M., Safronnikova N.R., Aylamazyan E.K., Selkov S.A., Vedeneeva G.N., Strukov E.L., Chukhlovin A.B., Zaraisky M.I., 22 O.V. Narva Infection and immunity Isakov V.A., Ermolenko D.K., Borovtsova T.M., Shlygin S.A., Vyatkina G.P., Petrova T.F., Bulatova N.V., Nevalennaya G.I., Kozikova I.A., Katkevichene E.V., Arkhipov A.V., Mishkin V.I., Lyshev A.A., Kasatkin E.V., Zavadskaya T.N. Organization and conduct of screening for the presence of oncogenic human papillomavirus in order to prevent malignant neoplasms of the organs of the reproductive system: Methodological recommendations. — St. Petersburg, 2005. — 28 p.
Hanson K.P., Imyanitov E.N. Modern ideas about the carcinogenesis of cervical cancer // Practical oncology. - 2002. — Vol. 3, No. 3. — pp. 145-155.
Shipulina O.Yu. The occurrence of human papillomavirus genotypes of high carcinogenic risk in cancer and precancerous pathology of the cervix // Papillomavirus infection and malignant neoplasms. Integrated surveillance and prevention system: materials of the International the symposium. — St. Petersburg: NIIEM im. Pasteur, 2009. — pp. 40-44.11. Apgar B.S., Zoschnick L., Wright T.C. Jr. The 2001 Bethesda system terminology // Am. Fam. Physician. — 2003. — Vol. 68, N 15. — P. 1992–1998.
Doorbar J. The papillomavirus life cycle // J. Clin. Virol. — 2005. — Jg. 32 (Suppl. 1). — S. 7–15.
Mu oz N. Castellsagu X., Gonz les A., Gissmann L. HPV in the ethiology of human cancer // Vaccine. — 2006. — Vol. 24, Suppl. 3. — S. 3–10.
Papanicolaou G.N. Atlas of exfoliative cytology. — Cambridge: Harvard Univ. Press, 1963. — 438 p
